Legal Opinion
Blue Cross Blue Shield v. AstraZeneca Pharmaceuticals LP
Court of Appeals for the First Circuit
Decided September 23, 2009No. 08-1056PublishedCited by 10 opinions
1Opinion of the Court
HOWARD, Circuit Judge.
AstraZeneca Pharmaceuticals LP (“AstraZeneca”) appeals from the judgment of the district court, entered after a lengthy bench trial, of liability for unfair and deceptive business practices in violation of Massachusetts General Laws Chapter 93A (“Chapter 93A”). In re Pharm. Indus. Average Wholesale Price Litig., 491 F.Supp.2d 20 (D.Mass.2007). The district court found that AstraZeneca had caused the publication of false and inflated average wholesale prices (“AWPs”), a price used as a benchmark for various reimbursement plans, for its physician-administered drug Zoladex…
2Cases cited87 opinions
- Daubert v. Merrell Dow Pharmaceuticals, Inc.Supreme Court of the United States · 1993
- Anderson v. City of Bessemer CitySupreme Court of the United States · 1985
- Amchem Products, Inc. v. WindsorSupreme Court of the United States · 1997
- General Electric Co. v. JoinerSupreme Court of the United States · 1997
- United States v. Ilario M.A. ZanninoCourt of Appeals for the First Circuit · 1990
82 more not listed; retrieve them via the Exa API.
3Cited by10 opinions
- In Re Pharm. Industry Average Wholesale Price Lit.Court of Appeals for the First Circuit · 2009
- Watson Laboratories, Inc. v. State of MississippiMississippi Supreme Court · 2018
- New York City Health & Hospitals Corp. v. Wellcare of New York, Inc.District Court, S.D. New York · 2011
- Stern v. American Home Mortgage Servicing, Inc. (In re Asher)United States Bankruptcy Court, E.D. New York · 2013
- Corrigan v. Covidien LPDistrict Court, D. Massachusetts · 2022
5 more not listed; retrieve them via the Exa API.